Genmab A/S (NASDAQ:GMAB), a Denmark-based biotechnology company with a market capitalization of $13.4 billion, announced today that it has granted restricted stock units and warrants to its employees.

Ultratech Cement reported a 17% YoY decline in its net profit in the December quarter. Volume is was recorded at 10% YoY.

Tesla reports fourth-quarter earnings and revenue next week and while the EV giant's profit and delivery guidance will be important for investors, so too are several key timelines for products Chief ...